Marginal structural Cox models (MSCMs) have gained popularity in analyzing longitudinal data in the presence of 'time-dependent confounding', primarily in the context of HIV/AIDS and related conditions. This thesis is motivated by issues arising in connection with dealing with time-dependent confounding while assessing the effects of beta-interferon drug exposure on disease progression in relapsing-remitting multiple sclerosis (MS) patients in the real-world clinical practice setting. In the context of this chronic, yet fluctuating disease, MSCMs were used to adjust for the time-varying confounders, such as MS relapses, as well as baseline characteristics, through the use of inverse probability weighting (IPW). Using a large cohort of 1,697...
Establishing the long-term benefit of therapy in chronic diseases has been challenging. Long-term st...
Establishing the long-term benefit of therapy in chronic diseases has been challenging. Long-term st...
OBJECTIVES: To develop a model of disease progression using multiple sclerosis (MS) as an exempla...
Marginal structural Cox models (MSCMs) have gained popularity in analyzing longitudinal data in the ...
When estimating the effect of treatment on HIV using data from observational studies, standard metho...
When estimating the effect of treatment on HIV using data from observational studies, standard metho...
When estimating the effect of treatment on HIV using data from observational studies, standard metho...
Much of epidemiology and clinical medicine is focused on estimating the effects of treatments or int...
Much of epidemiology and clinical medicine is focused on estimating the effects of treatments or int...
The course of multiple sclerosis (MS) is generally difficult to predict. This is due to the great in...
AbstractObjectivesTo develop a model of disease progression using multiple sclerosis (MS) as an exem...
The course of multiple sclerosis (MS) is generally difficult to predict. This is due to the great in...
The course of multiple sclerosis (MS) is generally difficult to predict. This is due to the great in...
The course of multiple sclerosis (MS) is generally difficult to predict. This is due to the great in...
The course of multiple sclerosis (MS) is generally difficult to predict. This is due to the great in...
Establishing the long-term benefit of therapy in chronic diseases has been challenging. Long-term st...
Establishing the long-term benefit of therapy in chronic diseases has been challenging. Long-term st...
OBJECTIVES: To develop a model of disease progression using multiple sclerosis (MS) as an exempla...
Marginal structural Cox models (MSCMs) have gained popularity in analyzing longitudinal data in the ...
When estimating the effect of treatment on HIV using data from observational studies, standard metho...
When estimating the effect of treatment on HIV using data from observational studies, standard metho...
When estimating the effect of treatment on HIV using data from observational studies, standard metho...
Much of epidemiology and clinical medicine is focused on estimating the effects of treatments or int...
Much of epidemiology and clinical medicine is focused on estimating the effects of treatments or int...
The course of multiple sclerosis (MS) is generally difficult to predict. This is due to the great in...
AbstractObjectivesTo develop a model of disease progression using multiple sclerosis (MS) as an exem...
The course of multiple sclerosis (MS) is generally difficult to predict. This is due to the great in...
The course of multiple sclerosis (MS) is generally difficult to predict. This is due to the great in...
The course of multiple sclerosis (MS) is generally difficult to predict. This is due to the great in...
The course of multiple sclerosis (MS) is generally difficult to predict. This is due to the great in...
Establishing the long-term benefit of therapy in chronic diseases has been challenging. Long-term st...
Establishing the long-term benefit of therapy in chronic diseases has been challenging. Long-term st...
OBJECTIVES: To develop a model of disease progression using multiple sclerosis (MS) as an exempla...